Lanreotid Advanz Pharma 60 mg
Lanreotid Advanz Pharma 60 mg is a medicine authorised by Swissmedic under authorisation number 70157. The authorisation holder is Advanz Pharma Specialty Medicine Switzerland GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 18 August 2026 and the authorisation is limited until 17 August 2031. ATC code H01CB03 places the medicine in the group Pituitary and hypothalamic hormones and analogues.
| Authorisation number | 70157 |
|---|---|
| Name | Lanreotid Advanz Pharma 60 mg |
| Full name | Lanreotid Advanz Pharma 60 mg, Depot-Injektionslösung in einer Fertigspritze |
| Authorisation holder | Advanz Pharma Specialty Medicine Switzerland GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | H01CB03 |
| First authorisation | 18 August 2026 |
| Authorisation validity | 17 August 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Lanreotid Advanz Pharma 60 mg, Depot-Injektionslösung in einer Fertigspritze | A | 18 August 2026 |
| 2 | Lanreotid Advanz Pharma 90 mg, Depot-Injektionslösung in einer Fertigspritze | A | 18 August 2026 |
| 3 | Lanreotid Advanz Pharma 120 mg, Depot-Injektionslösung in einer Fertigspritze | A | 18 August 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Fertigspritze(n) | H01CB03 | 07.16.2. | A |
| 2 | 1 | Fertigspritze(n) | H01CB03 | 07.16.2. | A |
| 3 | 1 | Fertigspritze(n) | H01CB03 | 07.16.2. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Lanreotid Advanz Pharma 60 mg authorised in Switzerland?
Yes. Lanreotid Advanz Pharma 60 mg is authorised by Swissmedic under authorisation number 70157, data as of 01 September 2026. The authorisation is limited until 17 August 2031.
Which dispensing category does Lanreotid Advanz Pharma 60 mg have?
Lanreotid Advanz Pharma 60 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Lanreotid Advanz Pharma 60 mg?
The authorisation holder is Advanz Pharma Specialty Medicine Switzerland GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.